ArticleRadiation oncology (London, England)2022

Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer.

Hiroshi Mayahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.